Literature DB >> 26201007

Circulating levels of irisin is elevated in hypothyroidism, a case-control study.

İhsan Ateş1, Mustafa Altay1, Canan Topçuoğlu2, Fatma Meriç Yılmaz2.   

Abstract

Objective Our objective in this study was to determine the relationship between irisin hormone, which has a similar effect with thyroid hormones on adipose tissue and the metabolism, and the thyroid functions and the obesity secondary to thyroid disease. Subjects and methods Seventy-four patients were included in the study, of the patients, 37 were newly diagnosed with Hashimoto's thyroiditis related hypothyroidism but not started on a treatment yet, and the remaining 37 were healthy volunteers without a known disease. Serum thyroid stimulating hormone (TSH), free thyroxin (fT4), anti-thyroglobulin and anti-thyroid peroxidase were measured and thyroid ultrasonography was performed in both groups. Serum irisin levels were measured using the commercially available ELISA kit. The hypothyroidism group had higher levels of irisin compared to the control group (2.77 ng/mL vs. 2.15 ng/mL respectively; p = 0.017). Results The hypothyroidism group had higher median levels of irisin in the obese patients than those in the control group (3.10 ng/mL vs. 2.10 ng/mL respectively; p = 0.013). Irisin level was negatively correlated with age in the whole population and patients with hypothyroidism (r = -0.255, p = 0.028; r = -0.346, p = 0.036 respectively). Irisin level was positively correlated with TSH (r = 0.247, p = 0.034) but negatively correlated with the fT4 (r = -0.316, p = 0.006) in the whole population. Obesity, fT4 and irisin levels were identified to be independent predictors in the diagnosis of hypothyroidism in the multivariable logistic regression analysis. Conclusion To the best of our knowledge, this study is the first in literature to identify that obesity, irisin level and fT4 level are independent risk factors for hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26201007     DOI: 10.1590/2359-3997000000077

Source DB:  PubMed          Journal:  Arch Endocrinol Metab        ISSN: 2359-3997            Impact factor:   2.309


  7 in total

1.  Irisin levels increase after treatment in patients with newly diagnosed Hashimoto thyroiditis.

Authors:  Z A Uc; S Gorar; S Mizrak; S Gullu
Journal:  J Endocrinol Invest       Date:  2018-05-18       Impact factor: 4.256

2.  Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors.

Authors:  Theodora Stratigou; Maria Dalamaga; Georgios Antonakos; Ioanna Marinou; Evaggelos Vogiatzakis; Gerasimos Socrates Christodoulatos; Irene Karampela; Athanasios G Papavassiliou
Journal:  Endocrine       Date:  2018-02-17       Impact factor: 3.633

3.  Association of serum irisin concentration with thyroid autoantibody positivity and subclinical hypothyroidism.

Authors:  Zhengyi Chen; Qiao Zhang; Nianchun Peng; Ying Hu; Hong Li; Xi He; Ruoyi Liu; Shujing Xu; Miao Zhang; Lixin Shi
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

4.  Role of irisin in Chinese patients with hypothyroidism: an interventional study.

Authors:  Ning Yang; Heng Zhang; Xia Gao; Li Miao; Zhi Yao; Yuan Xu; Guang Wang
Journal:  J Int Med Res       Date:  2019-02-06       Impact factor: 1.671

5.  Irisin as a Potential Biomarker Associated with Myocardial Injuries in Patients with Severe Hypothyroidism.

Authors:  Zhi Yao; Xiaoyu Ding; Xia Gao; Ning Yang; Yumei Jia; Jia Liu; Guang Wang
Journal:  Int J Endocrinol       Date:  2021-11-18       Impact factor: 3.257

6.  Thyroid hormones modulate irisin concentrations in patients with recently onset hypothyroidism following total thyroidectomy.

Authors:  R Bocale; A Barini; A D'Amore; M Boscherin; S Necozione; A Barini; G Desideri; C P Lombardi
Journal:  J Endocrinol Invest       Date:  2020-10-14       Impact factor: 4.256

7.  Circulating Irisin Level and Thyroid Dysfunction: A Systematic Review and Meta-Analysis.

Authors:  Dan Shan; Li Zou; Xijiao Liu; Yitong Cai; Ruihong Dong; Yayi Hu
Journal:  Biomed Res Int       Date:  2020-10-28       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.